Praxis Medica
Sign in
Issue image

More articles from Volume 37, Issue 2, 2009

FUNCTIONAL ASYMMETRY OF BRAIN AND POTENTIALS P300

INFLUENCE OF DOXORUBICIN ON ELECTRICAL ACTIVITY OF THE MYOCARDIUM AND LEFT VENTRICULAR FUNCTION DURING TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

MORPHOMETRIC AND STEREOLOGICAL ANALYSIS GANGLION STRUCTURES OF MYENTERIC NERVE PLEXUS, TERMINALLY PART OF HUMAN LARGE INTESTINE

MASSIVENESS OF A SICKNESS, A PATHOGENIC OF CONTAGIUM AND HENLE-KOCH POSTULATES

SOME ASPECTS OF FAMILY PLANNING - FROM MISCARRIAGE TO HEALTH EDUCATION

ELECTROCARDIOGRAPHIC CHANGES IN PATIENTS WITH SYSTEMIC DISEASE OF CONNECTIVE TISSUE

E. Regić ,
E. Regić

Novi Pazar health center Serbia

View authors publications

Search this author on:

PubMed | Google Scholar
S. Sovtić
S. Sovtić

Internal clinic, Medical faculty Priština , Kosovska Mitrovica , Kosovo*

View authors publications

Search this author on:

PubMed | Google Scholar

Published: 01.12.2009.

Volume 37, Issue 2 (2009)

pp. 77-80;

https://doi.org/10.70949/pramed200902300R

Abstract

Changes in the heart and blood vessels are one of the major complications that substantially contribute to morbidity and mortality of patients with systemic diseases of connective tissue.All anatomical structures of the heart can be affected by pathological process and noted the multiple pathogenic mechanism leading to changes in pericard (thickening of leaves, calcification, pericardial outburst), atrial and ventricular arrhythmia, disorders of implementation, changes in heart failure in terms of whiskered or stenosis, myocardial ischemia and heart failure. The aim was also to test the registration of the most common heart rhythm disorder and implementation as well as changes in the ST segment and T wave of electrocardiogram of patients with systemic diseases of connective tissue. The study involved 70 patients in two groups. The first group was 50 patients with systemic disease of connective tissue, and the second control group of 20 patients with lumbal syndrome. Electrocardiographic changes were observed in 38(54,3%) respondents. Observed by groups of patients with connective tissue diseases were registered in 35 (70%) and in the control group in 3 (15%) patients with a statistically significant difference (p<0,01). Statistically significant difference was noted in the appearance of ventricular premature complex, changes in ST segment and T wave.

Keywords

electrocardiographic changes,

systemic disease of connective tissue

References

1.
Seferovic PM, Ristic AD, Maksimovic R. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology. 45 Suppl. 4:39–42.
2.
Iliæ S. Osnovi elektrokardiografije.
3.
Volta U, Villecco AS, Bianchi FB. Antibodies to cardiac conducting tissue in progressive systemic sclerosis. Clin Exp Rheumatol. 3:131–5.
4.
Shur D, Rozman WC. The heart in systemic lupus erythematosus and changes induced in it by corticosteroid therapy: a study of 36 patients. Am J Med. :243–58.
5.
Yttenberg S, Mahowald M. Exercise for arthritis. Clin Rheumatol. 8:161.
6.
Maione S, Valentini G, Giunta A. Cardiac involvement in rheumatoid arthritis. Cardiology. 83:234–9.
7.
Kažiæ T, Ostojiæ M. Klinička kardiovaskularna farmakologija. :407–37.
8.
Sach R, Hart FD, Walker B. Rheumatoid arthritis: extra-articular manifestations. Part II. Br Med J. 9:549–62.
9.
Nikoliæ M, Maksimoviæ D. Kompletan srčani blok u reumatoidnom artritisu. 42:389–96.
10.
Silver RM. Scleroderma: Clinical problems. The lungs. Rheum Dis Clin North Am. 22:825–40.
11.
Buyon J. Autoimmune-associated congenital heart block: demographics, mortality, morbidity, and recurrence rates obtained from a national lupus registry. J Am Coll Cardiol. 31:1685–90.
12.
M. MC, PM S. Heart involvement in autoimmune rheumatic diseases: the “phantom of the opera.” Rheumatology. 45 Suppl. 4:1–3.
13.
Sauleda I. Purulent pericarditis: Review of a 20-year experience in a general hospital. J Am Coll Cardiol. 22:1661.
14.
Bulkley AD, Roberts AD, Roberts M. Spectrum and progression of conduction abnormalities with anti-SSA/Ro, anti-SSB/La antibodies. Lupus. 11:193–9.
15.
Conley S, Hartman N. Morbidity and mortality in systemic lupus erythematosus during a year period: a multicenter prospective study of 1000 patients. Medicine. :159–66.
16.
Doherty G, Siegal L. Cardiac involvement in systemic autoimmune disease.
17.
Stollerman MD, Hughes GRV. Cardiovascular manifestations of systemic lupus erythematosus.
18.
Mutru O, Lakso M, Isomaki H, Koota K. Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology. 76:71–7.
19.
Cruz D, Khamashta M, Hughes GRV. Cardiovascular manifestations of systemic lupus erythematosus.
20.
Lazzerini PE, Capecchi PL, Guideri F. Connective tissue diseases and cardiac rhythm disorders: An overview. Autoimmun Rev. 5:306–13.
21.
Sovtic S. Propedevtika kardiovaskularnog sistema. Kos Mitrovica. :103–11.

Citation

Copyright

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by
DOAJ
Google Scholar
ERIHPLUS
MIAR I
Crossref